Disease transmission

Clinical trials

Transfusion of Pathogen-Reduced Red Blood Cells Yields Noninferior Outcomes for Acute Kidney Injury in Cardiac Surgery Patients

Researchers from Yale University School of Medicine have conducted a phase 3 trial to investigate the safety and efficacy of transfusing amustaline/glutathione pathogen-reduced red blood cells in cardiac surgery patients with increased risk of red cell transfusion. The trial, which randomized 581 subjects, found that transfusion of pathogen-reduced red